Waters (WAT) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
3.0B
Gross Profit
1.8B
59.43%
Operating Income
837.9M
28.32%
Net Income
637.8M
21.56%
EPS (Diluted)
$10.71
Balance Sheet Metrics
Total Assets
4.6B
Total Liabilities
2.7B
Shareholders Equity
1.8B
Debt to Equity
1.49
Cash Flow Metrics
Operating Cash Flow
762.1M
Free Cash Flow
619.6M
Revenue & Profitability Trend
Waters Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 3.0B | 3.0B | 3.0B | 2.8B | 2.4B |
| Cost of Goods Sold | 1.2B | 1.2B | 1.2B | 1.2B | 1.0B |
| Gross Profit | 1.8B | 1.8B | 1.7B | 1.6B | 1.4B |
| Operating Expenses | 873.2M | 911.0M | 834.2M | 795.3M | 694.5M |
| Operating Income | 837.9M | 817.7M | 883.2M | 826.9M | 653.6M |
| Pre-tax Income | 754.9M | 736.2M | 837.8M | 806.2M | 610.9M |
| Income Tax | 117.0M | 94.0M | 130.1M | 113.4M | 89.3M |
| Net Income | 637.8M | 642.2M | 707.8M | 692.8M | 521.6M |
| EPS (Diluted) | $10.71 | $10.84 | $11.73 | $11.17 | $8.36 |
Income Statement Trend
Waters Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 1.7B | 1.8B | 1.8B | 1.6B | 1.4B |
| Non-Current Assets | 2.9B | 2.9B | 1.5B | 1.5B | 1.4B |
| Total Assets | 4.6B | 4.6B | 3.3B | 3.1B | 2.8B |
| Liabilities | |||||
| Current Liabilities | 789.8M | 789.6M | 785.7M | 680.5M | 805.0M |
| Non-Current Liabilities | 1.9B | 2.7B | 2.0B | 2.0B | 1.8B |
| Total Liabilities | 2.7B | 3.5B | 2.8B | 2.7B | 2.6B |
| Equity | |||||
| Total Shareholders Equity | 1.8B | 1.2B | 504.5M | 367.6M | 232.1M |
Balance Sheet Composition
Waters Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 637.8M | 642.2M | 707.8M | 692.8M | 521.6M |
| Operating Cash Flow | 762.1M | 603.6M | 611.7M | 757.0M | 783.6M |
| Investing Activities | |||||
| Capital Expenditures | -142.5M | -160.6M | -175.9M | -161.3M | -172.4M |
| Investing Cash Flow | -144.0M | -1.4B | -100.4M | -224.6M | -264.1M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | -727.0M | 725.2M | -552.4M | -493.9M | -506.5M |
| Free Cash Flow | 619.6M | 442.2M | 428.2M | 579.0M | 618.1M |
Cash Flow Trend
Waters Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
32.05
Forward P/E
27.29
Price to Book
10.70
Price to Sales
7.04
PEG Ratio
27.29
Profitability Ratios
Profit Margin
22.02%
Operating Margin
22.93%
Return on Equity
40.82%
Return on Assets
11.61%
Financial Health
Current Ratio
1.81
Debt to Equity
78.58
Beta
1.12
Per Share Data
EPS (TTM)
$11.01
Book Value per Share
$32.98
Revenue per Share
$50.24
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| wat | 21.0B | 32.05 | 10.70 | 40.82% | 22.02% | 78.58 |
| Thermo Fisher | 160.6B | 24.95 | 3.25 | 13.70% | 15.19% | 69.23 |
| Danaher | 146.6B | 39.70 | 2.88 | 7.22% | 15.81% | 34.56 |
| Idexx Laboratories | 42.5B | 48.75 | 29.47 | 59.33% | 22.76% | 73.16 |
| Agilent Technologies | 35.0B | 30.36 | 5.70 | 18.88% | 17.59% | 60.04 |
| Iqvia Holdings | 27.7B | 21.85 | 4.66 | 21.64% | 8.61% | 242.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.